Standard Glass Lining Technology has entered into a Target-Based Conditional Distribution Agreement with API Pharma Pharmaceutical Trading L.L.C, for the Middle East Region as part of its export expansion strategy. The agreement provides for an initial 3 years performance period with defined annual and cumulative business targets. Subject to achievement of these milestones, the arrangement shall continue for a total tenure of upto 10 years. 

This arrangement is intended to strengthen the company’s export presence in the Middle East region across: Pharmaceutical manufacturing facilities, Biopharmaceutical and life sciences, Food & Beverages and other process industries. The Middle East region continues to witness sustained investments in pharmaceutical self-sufficiency, biopharma capacity creation, food security programs and diversified industrial infrastructure under long-term economic transformation initiatives. The agreement enables the company to participate in such export-driven growth opportunities through a performance-linked and risk-calibrated model.

Standard Glass Lining Technology is one of the specialized engineering equipment manufacturers for pharmaceutical and chemical sectors in India, with in house capabilities across the entire value chain.